DTCFF
Price
$0.39
Change
-$0.12 (-23.53%)
Updated
Oct 2 closing price
Capitalization
29.77M
VERA
Price
$30.94
Change
+$0.80 (+2.65%)
Updated
Oct 6 closing price
Capitalization
1.97B
29 days until earnings call
Interact to see
Advertisement

DTCFF vs VERA

Header iconDTCFF vs VERA Comparison
Open Charts DTCFF vs VERABanner chart's image
DEFENCE THERAPEUTICS
Price$0.39
Change-$0.12 (-23.53%)
Volume$100
Capitalization29.77M
Vera Therapeutics
Price$30.94
Change+$0.80 (+2.65%)
Volume$1.45M
Capitalization1.97B
DTCFF vs VERA Comparison Chart in %
DTCFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTCFF vs. VERA commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTCFF is a Hold and VERA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (DTCFF: $0.39 vs. VERA: $30.94)
Brand notoriety: DTCFF and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTCFF: 3% vs. VERA: 83%
Market capitalization -- DTCFF: $29.77M vs. VERA: $1.97B
DTCFF [@Biotechnology] is valued at $29.77M. VERA’s [@Biotechnology] market capitalization is $1.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTCFF’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 1 green FA rating(s).

  • DTCFF’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 1 green, 4 red.
According to our system of comparison, VERA is a better buy in the long-term than DTCFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTCFF’s TA Score shows that 3 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • DTCFF’s TA Score: 3 bullish, 5 bearish.
  • VERA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VERA is a better buy in the short-term than DTCFF.

Price Growth

DTCFF (@Biotechnology) experienced а -28.06% price change this week, while VERA (@Biotechnology) price change was +7.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.91%. For the same industry, the average monthly price growth was +14.77%, and the average quarterly price growth was +84.62%.

Reported Earning Dates

VERA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.98B) has a higher market cap than DTCFF($29.8M). DTCFF YTD gains are higher at: 0.513 vs. VERA (-26.838). DTCFF has higher annual earnings (EBITDA): -3.16M vs. VERA (-210.52M). VERA has more cash in the bank: 557M vs. DTCFF (2.08M). DTCFF has less debt than VERA: DTCFF (1.39M) vs VERA (77.6M). DTCFF (0) and VERA (0) have equivalent revenues.
DTCFFVERADTCFF / VERA
Capitalization29.8M1.98B2%
EBITDA-3.16M-210.52M2%
Gain YTD0.513-26.838-2%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.08M557M0%
Total Debt1.39M77.6M2%
TECHNICAL ANALYSIS
Technical Analysis
DTCFFVERA
RSI
ODDS (%)
Bullish Trend 4 days ago
54%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
59%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
69%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 4 days ago
69%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
68%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
63%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DTCFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LPEIX7.01N/A
N/A
ALPS Global Opportunity I
MUXRX28.96N/A
N/A
Victory S&P 500 Index R
OGIYX52.64N/A
N/A
Invesco Global Opportunities Y
JMGPX53.96N/A
N/A
JPMorgan Mid Cap Growth R3
FNGRX18.24N/A
N/A
Franklin Intl Growth R

DTCFF and

Correlation & Price change

A.I.dvisor tells us that DTCFF and VERA have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DTCFF and VERA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTCFF
1D Price
Change %
DTCFF100%
N/A
VERA - DTCFF
14%
Poorly correlated
+2.65%
BRNS - DTCFF
11%
Poorly correlated
+8.62%
MOLN - DTCFF
7%
Poorly correlated
+1.08%
VALN - DTCFF
6%
Poorly correlated
-3.25%
LYEL - DTCFF
5%
Poorly correlated
+0.56%
More